CDEK
← All organizations
Aquestive Therapeutics

Aquestive Therapeutics

For profitWebsite ↗

Also known as: AQUESTIVE | AQUESTIVE THERAP | Aquestive Therapeutics | MonoSol Rx

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2008

First marketed drug

Jul 2, 2010

Last known activity

Jul 17, 2024

Timeline

2000s

  1. Jun 1, 2004

    Aquestive Therapeutics— Founded

2010s

  1. Jul 2, 2010

    ondansetron— Marketing Organization

  2. Jul 2, 2010

    ondansetron— NDA Secondary Org

Drugs by trial phase (5 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (4)

Recent trials (9)

Details

Founded
Warren Township, NJ, US Jun 1, 2004
Last known activity
Jul 17, 2024